Vychytil A - Search Results

1

Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis.

Tobudic S, Matzneller P, Stoiser B, Wenisch JM, Zeitlinger M, Vychytil A, Jaeger W, Boehmdorfer M, Reznicek G, Burgmann H. Tobudic S, et al. Among authors: vychytil a. Antimicrob Agents Chemother. 2012 Jul;56(7):3992-5. doi: 10.1128/AAC.00126-12. Epub 2012 May 7. Antimicrob Agents Chemother. 2012. PMID: 22564843 Free PMC article.

2

Iron status and iron supplementation in peritoneal dialysis patients.

Vychytil A, Haag-Weber M. Vychytil A, et al. Kidney Int Suppl. 1999 Mar;69:S71-8. doi: 10.1046/j.1523-1755.1999.055suppl.69071.x. Kidney Int Suppl. 1999. PMID: 10084290 Free article. Review.

3

Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients.

Vychytil A, Födinger M, Papagiannopoulos M, Wölfl G, Hörl WH, Sunder-Plassmann G. Vychytil A, et al. Kidney Int. 1999 May;55(5):2054-61. doi: 10.1046/j.1523-1755.1999.00437.x. Kidney Int. 1999. PMID: 10231471 Free article.

4

A case of continuous ambulatory peritoneal dialysis peritonitis with an uncommon organism and an atypical clinical course.

Konner P, Watschinger B, Apfalter P, Hörl WH, Vychytil A. Konner P, et al. Among authors: vychytil a. Am J Kidney Dis. 2001 Jan;37(1):E10. doi: 10.1016/s0272-6386(01)90007-1. Am J Kidney Dis. 2001. PMID: 11136199

5

Is absorption of high-dose oral iron sufficient in peritoneal dialysis patients?

Dittrich E, Puttinger H, Schneider B, Hörl WH, Haag-Weber M, Vychytil A. Dittrich E, et al. Among authors: vychytil a. Perit Dial Int. 2000 Nov-Dec;20(6):667-73. Perit Dial Int. 2000. PMID: 11216557

6

Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.

Dittrich E, Schillinger M, Sunder-Plassmann G, Hörl WH, Vychytil A. Dittrich E, et al. Among authors: vychytil a. Perit Dial Int. 2002 Jan-Feb;22(1):60-6. Perit Dial Int. 2002. PMID: 11929146

7

Hepatitis B and C in peritoneal dialysis patients.

Puttinger H, Vychytil A. Puttinger H, et al. Among authors: vychytil a. Semin Nephrol. 2002 Jul;22(4):351-60. Semin Nephrol. 2002. PMID: 12118400 Review.

8

Acute effect of amino acid peritoneal dialysis solution on vascular function.

Vychytil A, Födinger M, Pleiner J, Müllner M, Konner P, Skoupy S, Röhrer C, Wolzt M, Sunder-Plassmann G. Vychytil A, et al. Am J Clin Nutr. 2003 Nov;78(5):1039-45. doi: 10.1093/ajcn/78.5.1039. Am J Clin Nutr. 2003. PMID: 14594793 Clinical Trial.

9

Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.

Dittrich E, Puttinger H, Schillinger M, Lang I, Stefenelli T, Hörl WH, Vychytil A. Dittrich E, et al. Among authors: vychytil a. Nephrol Dial Transplant. 2006 May;21(5):1334-9. doi: 10.1093/ndt/gfi023. Epub 2005 Jul 26. Nephrol Dial Transplant. 2006. PMID: 16046499

10

Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.

Schaller G, Scheiber-Mojdehkar B, Wolzt M, Puttinger H, Mittermayer F, Hörl WH, Födinger M, Sunder-Plassmann G, Vychytil A. Schaller G, et al. Among authors: vychytil a. Kidney Int. 2005 Dec;68(6):2814-22. doi: 10.1111/j.1523-1755.2005.00754.x. Kidney Int. 2005. PMID: 16316358 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters